Summary
In April 2021, The National Institute for Health and Care Excellence (NICE) released new guidance on the management of chronic pain.
In The British Pain Society's (BPS) initial statement on the NICE guideline, they conclude:
"In summary, the new NICE guideline NG193 acknowledges that individual and indeed specialised chronic pain assessment and management is required. However, The British Pain Society feels that the guidance as it stands could lead to the withdrawal of supervised short-term therapies which can work safely in carefully selected and monitored patients with forms of chronic primary pain."
Follow the link below to access the statement in full.
The British Pain Society's initial statement on NICE guideline NG193 on Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain (8 April 2021)
https://www.britishpainsociety.org/static/uploads/resources/files/BPS_statement_on_final_NICE_guideline_NG193_for_CPP_and_CSP_-_8_April_2021_FINAL.pdf
1
reactions so far
1 Comment
Recommended Comments
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now